Name: Was the folliculitis reported in the tapinarof trials problematic?
Uploaded: 2021-12-27T00:00:00.000Z
Description: Was the folliculitis reported in the tapinarof trials problematic?

Welcome to Dermbits! Watch short videos of KOLs answering your questions

thumbnail_dermbits-colorful.png

dermbits-colorful.png

Dermbits

Was the folliculitis reported in the tapinarof trials problematic?

Psoriasis

In the pivotal trials for DiPinrov, there were reports of folliculitis, which, again, were not a dose limiting nor a tendency to drop out of the trials, even though they were reported as an adverse event. And I think it's something we have to watch for. I think the mechanism of folliculitis still needs to be understood even more. So, it's not a sterile filiculitis versus an infectious filiculitis from what the reporting was. So I would be very reticent in not writing this drug once it comes out because of filiculitis, I would just definitely watch and consult patients on what's going to happen next, and then we would go from there.

Was the folliculitis reported in the tapinarof trials problematic?

Related CME